Sruthi Vellanki MD, MBA, FACP

Passionate hem Onc hospitalist, loving wife to my handsome hubby, devoted daughter, and a bit of a mischievous sister. awaiting adventures in Hem onc# FamilyFun

[Nishanth Thalambedu @Nishant37943085]

New Publication alert
🧵 Clinicians: Be alert for Hyperhemolysis Syndrome (HS) in SCD patients post-transfusion.
It’s rare, severe, and often underrecognized.
Here’s a quick clinical primer from our recent review 🧬👇
#Hematology #SickleCell #MedTwitter
https://t.co/DjZSvBkeJo

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

A nice perspective article on MRD @VincentRK @ZanwarSaurabh @LeukemiaJnl #ASH25 #mmsm

Nice table with summary of MRD-guided studies 👇

[Hematology Review @HematologyTweet]

Summary of immunotherapy activity against CNS disease in ALL

#ASH25

[Diagnostics MDPI @diagnostic_mdpi]

#diagnosis #hematological
'Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature'
by Sruthi Vellanki et al. @sruthivellankiT @Nishant37943085 @shivijain80 @CGentilleMD

👉Discover the full paper at https://t.co/M3rbtBwdrg

[Asis Shrestha, MD, FACP @asis_shr]

UAMS team gathering at poster 3789 #ASH24 presented by @Dr_Bhavesh_M

Prior Exposure to Belantamab Mafodotin Influences Outcomes with Idecabtagene Vicluecel in Patients with Multiple Myeloma

@HadidiSamer @AnupTrix @sruthivellankiT

[𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM @nihardesai89]

Previous trials tested hydroxyurea in patients with Hb SS but excluded patients with Hb SC!

Dr. Adomakoh reports the results of the PIVOT trial testing hydroxyurea in patients with HB SC || #ASH24 plenary 🙌🏼

Results simultaneously published in @NEJM evidence 💪🏼

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

#ASH24 #mmsm @ASH_hematology

Nice algorithm for therapeutic anticoagulation for cancer associated VTE

[Vincent Rajkumar @VincentRK]

My Annual Updated Myeloma Treatment Algorithms thread. Bookmark! #ASH24
#ASH24VR

1. Newly diagnosed transplant ineligible. Quadruplet unless frail. Maintenance varies by risk stratification.

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

#ASH24 @ASH_hematology #mmsm

Available MM therapies in 2025

[Nishanth Thalambedu @Nishant37943085]

Good timing right before #ASH2024

[Sruthi Vellanki MD, MBA, FACP @sruthivellankiT]

@Dr_Bhavesh_M @MuthuVeeraputh1 @HadidiSamer Congratulations Bhavesh!!!

[Sruthi Vellanki MD, MBA, FACP @sruthivellankiT]

@OgaKingsley @WinshipAtEmory Congratulations Kingsley. Proud of you

[Sruthi Vellanki MD, MBA, FACP @sruthivellankiT]

@GK_SJMO Congratulations Dr. GK and all those who matched. We appreciate your mentorship